Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
International Journal of Psychiatry in Medicine
|
March 12, 2015
The sadness connection
Kim A Reiss
Current Treatment Options in Oncology
|
February 4, 2024
Targeting BRCA and PALB2 in Pancreatic Cancer
Sriram Anbil, Kim A Reiss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2021
Alternatives to Perpetual Chemotherapy for Metastatic Pancreatic Cancer
Kim A Reiss, Robert H Vonderheide
Cancers
|
September 28, 2021
Determinants of Homologous Recombination Deficiency in Pancreatic Cancer
Max M Wattenberg, Kim A Reiss
Hematology/Oncology Clinics of North America
|
September 26, 2022
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma
William J Chapin, Kim A Reiss
Cancer Journal (Sudbury, Mass.)
|
December 14, 2021
PARP Inhibitors in Pancreatic Cancer
Timothy J Brown, Kim A Reiss
The American Journal of Medicine
|
March 26, 2011
Healthy, but comatose
Brian Houston, Kim A Reiss, Christian Merlo
JCO Oncology Practice
|
September 17, 2020
Reply to J. Warner-Cohen et al
Erin M Bange, Kim A Reiss, Ronac Mamtani
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 16, 2023
Advancements in Systemic Therapy for Pancreatic Cancer
Timothy J Brown, Kim A Reiss, Mark H O'Hara
Immunotherapy
|
May 13, 2014
Harnessing the power of the immune system via blockade of PD-1 and PD-L1: a promising new anticancer strategy
Kim A Reiss, Patrick M Forde, Julie R Brahmer
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
International Journal of Psychiatry in Medicine
|
March 12, 2015
The sadness connection
Kim A Reiss
Current Treatment Options in Oncology
|
February 4, 2024
Targeting BRCA and PALB2 in Pancreatic Cancer
Sriram Anbil, Kim A Reiss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2021
Alternatives to Perpetual Chemotherapy for Metastatic Pancreatic Cancer
Kim A Reiss, Robert H Vonderheide
Cancers
|
September 28, 2021
Determinants of Homologous Recombination Deficiency in Pancreatic Cancer
Max M Wattenberg, Kim A Reiss
Hematology/Oncology Clinics of North America
|
September 26, 2022
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma
William J Chapin, Kim A Reiss
Cancer Journal (Sudbury, Mass.)
|
December 14, 2021
PARP Inhibitors in Pancreatic Cancer
Timothy J Brown, Kim A Reiss
The American Journal of Medicine
|
March 26, 2011
Healthy, but comatose
Brian Houston, Kim A Reiss, Christian Merlo
JCO Oncology Practice
|
September 17, 2020
Reply to J. Warner-Cohen et al
Erin M Bange, Kim A Reiss, Ronac Mamtani
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 16, 2023
Advancements in Systemic Therapy for Pancreatic Cancer
Timothy J Brown, Kim A Reiss, Mark H O'Hara
Immunotherapy
|
May 13, 2014
Harnessing the power of the immune system via blockade of PD-1 and PD-L1: a promising new anticancer strategy
Kim A Reiss, Patrick M Forde, Julie R Brahmer
Page
of 7